Indigene Pharmaceuticals and Tata Industries Ltd (TIL) have entered into a strategic alliance with TIL taking a significant equity stake in Indigene. The latter is a biopharmaceutical company with its operations in Boston (US), Europe and India and is focused on developing and delivering molecular combination-based products. Speaking on the occasion of the announcement of the alliance, Mr. Ratan Tata, Chairman, TIL said, “The Tata group has been actively seeking new opportunities in knowledge based industries. Biotechnology and biopharmaceutical areas offer great potential in creating value and improving the quality of life for people around the world.” He added that Indigene is well equipped to meet the challenges of the future. Indigene is set to launch four consumer healthcare products in self-medication areas.